Effect of magnetic stimulation on the gene expression profile of in vitro cultured neural cells

Neuroscience Letters

Volumn 526, Issue 2, 2012, Pages 122-127

  Stock, M ^a   Kirchner, B ^a   Waibler, D ^b   Cowley, D E ^c   Pfaffl, M W ^a   Kuehn, R ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Therapeutic Electromagnetic Osteopathy   (Germany)

^c NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Cell response; Microelectrode array; Neurodegeneration; Real time RT PCR; Signal recording

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; EMBRYO; FEMALE; FRONTAL CORTEX; GENE EXPRESSION PROFILING; IN VITRO STUDY; MAGNETIC FIELD; MAGNETIC STIMULATION; MALE; MICROELECTRODE; MOUSE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; FRONTAL LOBE; GENE EXPRESSION PROFILING; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; NEURAL STEM CELLS; PRIMARY CELL CULTURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRIPTOME;

EID: 84865997924     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.024     Document Type: Article

References (35)

1. Aaron R.K., Boyan B.D., Ciombor D.M., Schwartz Z., Simon B.J. Stimulation of growth factor synthesis by electric and electromagnetic fields. Clinical Orthopaedics and Related Research 2004, 3:0-3. 7.
2. Arns M., Drinkenburg P., Kenemans L. The effects of slow and fast rTMS of the dorsolateral prefrontal cortex (DLPFC) in depression and neurophysiological predictors of treatment outcome. Neuroscience Letters 2011, 500:e21.
3. Arns M., Spronk D., Fitzgerald P.B. Potential differential effects of 9Hz rTMS and 10Hz rTMS in the treatment of depression. Brain Stimulation 2010, 3:124-126.
4. Brewer G.J. Isolation and culture of adult rat hippocampal neurons. Journal of Neuroscience Methods 1997, 71:143-155.
5. Brighton C.T., Wang W., Seldes R., Zhang G., Pollack S.R. Signal transduction in electrically stimulated bone cells. Journal of Bone and Joint Surgery - American Volume 2001, 1514-1523.
6. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 2009, 55:611-622.
7. Chen R.H., Chang C.T., Chen W.C., Tsai C.H., Tsai F.J. Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients. Journal of Clinical Laboratory Analysis 2006, 20:260-265.
8. Chen S., Zhang X.-J., Li L., Le W.-D. Current experimental therapy for Alzheimer's disease. Current Neuropharmacology 2007, 5:127-134.
9. Cotelli M., Calabria M., Manenti R., Rosini S., Zanetti O., Cappa S.F., Miniussi C. Improved language performance in Alzheimer disease following brain stimulation. Journal of Neurology, Neurosurgery and Psychiatry 2011, 82:794-797.
10. Dvinge H., Bertone P. HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinformatics 2009, 25:3325-3326.
11. Elahi B., Elahi B., Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function - systematic review of controlled clinical trials. Movement Disorders 2009, 24:357-363.
12. Ferreri F., Pasqualetti P., Määttä S., Ponzo D., Guerra A., Bressi F., Chiovenda P., Del Duca M., Giambattistelli F., Ursini F., Tombini M., Vernieri F., Rossini P.M. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation follow-up study. Neuroscience Letters 2011, 492:94-98.
13. Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J., Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J., Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S., Curtis D., Aph-1 Aph 1 and pen-2 are required for Notch pathway signaling gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Development Cell 2002, 3:85-97.
14. Fujiki M., Steward O. High frequency transcranial magnetic stimulation mimics the effects of ECS in upregulating astroglial gene expression in the murine CNS. Brain Research Molecular Brain Research 1997, 44:301-308.
15. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
16. Godfrey E.W., Nelson P.G., Schrier B.K., Breuer A.C., Ransom B.R. Neurons from fetal rat brain in a new cell culture system: a multidisciplinary analysis. Brain Research 1975, 90:1-21.
17. Gross G.W., Harsch A., Rhoades B.K., Göpel W. Odor, drug and toxin analysis with neuronal networks in vitro: extracellular array recording of network responses. Biosensors and Bioelectronics 1997, 12:373-393.
18. Kobayashi M., Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurology 2003, 2:145-156.
19. Kudo K., Yamada M., Takahashi K., Nishioka G., Tanaka S., Hashiguchi T., Fukuzako H., Takigawa M., Higuchi T., Momose K., Kamijima K., Yamada M. Repetitive transcranial magnetic stimulation induces kf-1 expression in the rat brain. Life Sciences 2005, 76:2421-2429.
20. Meyer J.F., Wolf B., Gross G.W. Magnetic stimulation and depression of mammalian networks in primary neuronal cell cultures. IEEE Transactions on Biomedical Engineering 2009, 56:1512-1523.
21. Mirnics K., Pevsner J. Progress in the use of microarray technology to study the neurobiology of disease. Nature Neuroscience 2004, 7:434-439.
22. Nardone R., Bergmann J., Kronbichler M., Kunz A., Klein S., Caleri F., Tezzon F., Ladurner G., Golaszewski S. Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration. Journal of Neural Transmission 2008, 115:1557-1562.
23. Nardone R., de Blasi P., Bergmann J., Caleri F., Tezzon F., Ladurner G., Golaszewski S., Trinka E. Theta burst stimulation of dorsolateral prefrontal cortex modulates pathological language switching: a case report. Neuroscience Letters 2011, 487:378-382.
24. Petit A., Kawarai T., Paitel E., Sanjo N., Maj M., Scheid M., Chen F., Gu Y., Hasegawa H., Salehi-Rad S., Wang L., Rogaeva E., Fraser P., Robinson B., St George-Hyslop P., Tandon A. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. Journal of Biological Chemistry 2005, 280:34025-34032.
25. Ridding M.C., Rothwell J.C. Is there a future for therapeutic use of transcranial magnetic stimulation?. Nature Review Neuroscience 2007, 8:559-567.
26. Rotem A., Moses E. Magnetic stimulation of one-dimensional neuronal cultures. Biophysical Journal 2008, 94:5065-5078.
27. Rowan M.J., Klyubin I., Wang Q., Anwyl R. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochemical Society Transactions 2005, 33:563-567.
28. Strittmatter S.M., Fankhauser C., Huang P.L., Mashimo H., Fishman M.C. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell 1995, 80:445-452.
29. Tesco G., Koh Y.H., Kang E.L., Cameron A.N., Das S., Sena-Esteves M., Hiltunen M., Yang S.-H., Zhong Z., Shen Y., Simpkins J.W., Tanzi R.E. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 2007, 54:721-737.
30. Vandesompele J., de Preter K., Pattyn F., Poppe B., van Roy N., de Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002, 3. RESEARCH0034.
31. D. Waibler, B. Langguth, V. Milnik, J. Kühlmorgen, M. Kienle, V. Zschorlich, H. Siebner, Diagnostik und Therapieabläufe mit Hilfe der Magnetstimulation in Theorie und Praxis, Workshop Medtronic (2007).
32. Weinman S. Calcium-binding proteins: an overview. Journal de Biologie Buccale 1991, 19:90-98.
33. Witusik M., Piaskowski S., Hulas-Bigoszewska K., Zakrzewska M., Gresner S.M., Azizi S.A., Krynska B., Liberski P.P., Rieske P. Successful elimination of non-neural cells and unachievable elimination of glial cells by means of commonly used cell culture manipulations during differentiation of GFAP and SOX2 positive neural progenitors (NHA) to neuronal cells. BMC Biotechnology 2008, 8:56.
34. Wu Z., Guo H., Chow N., Sallstrom J., Bell R.D., Deane R., Brooks A.I., Kanagala S., Rubio A., Sagare A., Liu D., Li F., Armstrong D., Gasiewicz T., Zidovetzki R., Song X., Hofman F., Zlokovic B.V. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nature Medicine 2005, 11:959-965.
35. Zhang C., Wu B., Beglopoulos V., Wines-Samuelson M., Zhang D., Dragatsis I., Südhof T.C., Shen J. Presenilins are essential for regulating neurotransmitter release. Nature 2009, 460:632-636.